Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2400 participants
OBSERVATIONAL
2022-04-27
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers
NCT03254901
Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT04914611
Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care Tool
NCT05144776
Current Situation of Health Care in Women With HBV or HCV Infection
NCT06579313
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
NCT01350648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persons in custody in Australia
Representative sample of 2400 people in prison from 25 representative prisons in Australia will participate in a biobehavioural survey involving point-of-care testing for HCV antibodies and RNA (if antibody positive), HBV surface antigens and antibodies, and HIV antibodies, and an interview-style survey.
Point-of-care hepatitis C antibody test
Qualitative point-of-care test for hepatitis C antibodies (saliva sample)
Point-of-care hepatitis C RNA test
Hepatitis C Viral Load point-of-care test (fingerstick wholeblood sample)
Point-of-care hepatitis B surface antibody test
Qualitative hepatitis B surface antibody point-of-care test (fingerstick wholeblood sample)
Point-of-care hepatitis B surface antigen test
Qualitative hepatitis B surface antigen point-of-care test (fingerstick wholeblood sample)
Point-of-care HIV antibody test
Qualitative HIV antibody point-of-care test (saliva sample)
Interview-style survey
Interview-style survey regarding demographics, risk behaviours, BBV testing and treatment history, and point-of-care testing acceptability
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Point-of-care hepatitis C antibody test
Qualitative point-of-care test for hepatitis C antibodies (saliva sample)
Point-of-care hepatitis C RNA test
Hepatitis C Viral Load point-of-care test (fingerstick wholeblood sample)
Point-of-care hepatitis B surface antibody test
Qualitative hepatitis B surface antibody point-of-care test (fingerstick wholeblood sample)
Point-of-care hepatitis B surface antigen test
Qualitative hepatitis B surface antigen point-of-care test (fingerstick wholeblood sample)
Point-of-care HIV antibody test
Qualitative HIV antibody point-of-care test (saliva sample)
Interview-style survey
Interview-style survey regarding demographics, risk behaviours, BBV testing and treatment history, and point-of-care testing acceptability
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Too mentally unwell to provide consent
* Profoundly intellectually impaired
* Unable to speak English and comprehend the survey.
Those excluded from participating in the study will be referred to the local prison clinic service for standard of care.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kirby Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexander Maconochie Centre
Hume, Australian Capital Territory, Australia
Bathurst Correctional Complex
Bathurst, New South Wales, Australia
John Morony Correctional Complex
Berkshire Park, New South Wales, Australia
Cessnock Correctional Centre
Cessnock, New South Wales, Australia
Mid North Coast Correctional Centre
Kempsey, New South Wales, Australia
South Coast Correctional Centre
Nowra, New South Wales, Australia
Silverwater Women's Correctional Centre
Silverwater, New South Wales, Australia
Wellington Correctional Centre
Wuuluman, New South Wales, Australia
Alice Springs Correctional Centre
Alice Springs, Northern Territory, Australia
Darwin Correctional Centre
Howard Springs, Northern Territory, Australia
Borallon Training and Correctional Centre
Ironbark, Queensland, Australia
Brisbane Women's Correctional Centre
Ironbark, Queensland, Australia
Wolston Correctional Centre
Ironbark, Queensland, Australia
Townsville Correctional Centre
Townsville, Queensland, Australia
Mobilong Prison
Murray Bridge, South Australia, Australia
Adelaide Women's Prison
Northfield, South Australia, Australia
Yatala Labour Prison
Northfield, South Australia, Australia
Mary Hutchinson Women's Prison
Risdon Vale, Tasmania, Australia
Risdon Maximum Prison
Risdon Vale, Tasmania, Australia
Ron Barwick Minimum Security Prison
Risdon Vale, Tasmania, Australia
Bunbury Regional Prison
Bunbury, Western Australia, Australia
Casuarina Prison
Casuarina, Western Australia, Australia
Roebourne Regional Prison
Roebourne, Western Australia, Australia
Bandyup Women's Prison
West Swan, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VISP1901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.